Evaluating the Efficacy of Pediatric Lipid Screening Alerts

Completed · Not applicable

Conditions studied: Hypercholesterolemia, Hypercholesterolemia, Familial, Hypercholesteremia in Children, Hyperlipidemia in Children

In brief

The purpose of the study is to evaluate prospectively the impact of different system alerts on the prescription of lipid panels to pediatric Geisinger patients (9-11 years old), as per the now-universal guidelines. This will help quantify the relative effectiveness of different alerts and combinations of alerts on provider prescribing behavior and patient uptake of screening.

Key facts

Study ID

NCT04118348

Run by

Geisinger Clinic

People needed

13340

Starts

2019-10-10

Expected to finish

2020-10-11

Last updated by the study team

2023-11-07

Who can join

Age: 9 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• male or female patients between the ages of 9 - 11
• seen within a primary care, cardiology, endocrinology, urgent care (CareWorks), or nutrition clinic at Geisinger

You may not qualify if…

• patients who have completed a lipid screen in the EMR
• patients who were determined to have familial hypercholesterolemia based on prior screening

Where it is running

• Geisinger Health System — Danville, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.